Practical modalities for prevention of fungal infections in cancer patients
- 1 January 1997
- journal article
- review article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 16 (1) , 32-41
- https://doi.org/10.1007/bf01575119
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patientsAnnals of Hematology, 1995
- Itraconazole in leukemic patients with invasive aspergillosis (IA): Impact on intensive chemotherapy completionEuropean Journal of Haematology, 1994
- A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignanciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Amphotericin B versus amphotericin B plus 5-flucytosine: Poor results in the treatment of proven systemic mycoses in neutropenic patientsInfection, 1994
- Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992
- Fungal infections in cancer patients: An international autopsy surveyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- A Pilot Study of Prophylactic Aerosolized Amphotericin B In Patients at Risk for Prolonged NeutropeniaLeukemia & Lymphoma, 1992
- Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantationThe American Journal of Medicine, 1991
- Antifungal Prophylaxis with Itraconazole in Prolonged Neutropenia: Correlation with Plasma LevelsMycoses, 1989